Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Matrix Scientific Group Manufactures First Complete Set of Stem Cell Disposable Devices.


SAN DIEGO -- Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXP BMXP Boston Metropolitan Exchange Point ) announced today that it has manufactured its first complete set of disposable instruments for stem cell stem cell

In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult.
 research and tissue transfer procedures. The Company anticipates entering full manufacturing of these instruments sometime late August 2005, conditional to passing the FDA's 510(k) process.

Brian Pockett, Managing Director and COO, said "We now have a complete set of our instruments and we are ready to start the next phase which is Beta testing pre-510(k). This process is anticipated to take two weeks, after which the Company can undergo the 510(k) testing with the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 that is necessary before the Company can begin distribution of its instruments."

Chairman David Koos noted "Bio-Matrix is on the verge On the Verge (or The Geography of Yearning) is a play written by Eric Overmyer. It makes extensive use of esoteric language and pop culture references from the late nineteenth century to 1955.  of entering the market with its first products. We believe, once we pass the 510(k) filing, that we will see our first revenues sometime in the third quarter this year. This is the beginning for us in meeting our Company's first objective of manufacturing and marketing a comprehensive line of disposable instrumentation for regenerative medical procedures involving stem cell technologies."

A Company spokesperson stated that Bio-Matrix Scientific Group is aggressively pursuing coming to market with its products. The starting the 510(k) process is a major step towards producing revenue.

More information will be available shortly on the Company's website: www.BMXGonline.com.

About Bio-Matrix Scientific Group Inc.:

Bio-Matrix Scientific Group Inc. is a development stage company in the business of medical devices and monitoring systems research, development and commercialization. Bio-Matrix Scientific Group Inc. is aligning itself with partners that offer key technologies in biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Other companies in the same industry as Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXP) are StemCells Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:STEM), Thermogenesis thermogenesis /ther·mo·gen·e·sis/ (-jen´e-sis) the production of heat, especially within the animal body.thermogenet´icthermogen´ic

ther·mo·gen·e·sis
n.
 Corporation (NASDAQ:KOOL KOOL Kentucky Offender Online Lookup
KOOL K-Based Object Oriented Language
) and Regeneration Technologies Inc. (NASDAQ:RTIX).

DISCLAIMER: This news release contains forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 22, 2005
Words:381
Previous Article:Jerry Schretter to Join UBS As Managing Director in Energy Investment Banking.
Next Article:Fitch Rates R.J. Reynolds' Proposed $500MM Debt Offering 'BB+'.



Related Articles
Bio-Matrix Scientific Exhibiting Stem Cell Instruments & Stem Cell Bank at the American Society of Plastic Surgeons Convention in Chicago September...
Bio-Matrix Scientific Signs Lease on 15,000 sq. ft. Building for Its Stem Cell Research Facility and Stem Cell Bank.
Bio-Matrix Issues Shareholder Update.
Bio-Matrix Scientific Group Inc. Starts Final Phase of Class 10,000 Processing Laboratory Installation.
Bio-Matrix Scientific Group Inc. Processing Laboratory Nearing Completion.
Bio-Matrix Announces Construction and Installation of the Class 10,000 Stem Cell Cellular Tissue Processing Laboratory Completed.
Bio-Matrix Scientific Receives Certificate of Compliance for Class 10,000 Processing Laboratory.
Bio-Matrix Scientific Enters into Validation and Protocol Process.
Bio-Matrix Scientific Enters into Contract with Validation Systems to Finalize FDA cGMP Quality Systems for First Adult Stem Cell Bank Focused on Fat...
Bio-Matrix Scientific CEO Highlights Plans for First Commercial Adult Stem Cell Bank Derived from Fat and Medical Devices Aimed at Plastic Surgeons...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles